Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

NCT01455649 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant
Immunosuppression

Interventions

DRUG: Everolimus
DRUG: calcineurin inhibitor

Sponsor

Deise de Boni Monteiro de Carvalho